The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Gfi-1B controls human erythroid and megakaryocytic differentiation by regulating TGF-β signaling at the bipotent erythro-megakaryocytic progenitor stage
Abstract
Growth factor independence-1B (Gfi-1B) is a transcriptional repressor essential for erythropoiesis and megakaryopoiesis. Targeted gene disruption of GFI1B in mice leads to embryonic lethality resulting from failure to produce definitive erythrocytes, hindering the study of Gfi-1B function in adult hematopoiesis. We here show that, in humans, Gfi-1B controls the development of erythrocytes and megakaryocytes by regulating the proliferation and differentiation of bipotent erythro-megakaryocytic progenitors. We further identify in this cell population the type III transforming growth factor-β receptor gene, TGFBR3, as a direct target of Gfi-1B. Knockdown of Gfi-1B results in altered transforming growth factor-β (TGF-β) signaling as shown by the increase in Smad2 phosphorylation and its inability to associate to the transcription intermediary factor 1-γ (TIF1-γ). Because the Smad2/TIF1-γ complex is known to specifically regulate erythroid differentiation, we propose that, by repressing TGF-β type III receptor (TβRΙII) expression, Gfi-1B favors the Smad2/TIF1-γ interaction downstream of TGF-β signaling, allowing immature progenitors to differentiate toward the erythroid lineage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“(1) RBCs contain several important miRNAs that are involved in erythropoiesis (Masaki et al., 2007; Fu et al., 2009; Randrianarison-Huetz et al., 2010; Xu et al., 2019);”
From Red Blood Cells as Potential Repositories of MicroRNAs in the Circulatory System (2020) · cites this paper as Randrianarison-Huetz et al., 2010
Experimental — accuracy not yet measuredIn the citing paper
“suggesting that miR-4732-3p plays an important role in promoting cell proliferation during erythroid differentiation”
From Red Blood Cells as Potential Repositories of MicroRNAs in the Circulatory System (2020) · cites this paper as Randrianarison-Huetz et al., 2010
In the citing paper
“Another study documented that miR-4732-3p within the erythroid-enriched miR-144/451 locus exhibits a high abundance in erythrocytes and targets two critical components (i.e., SMAD2 and SMAD4) of the transforming growth factor beta (TGF-β) pathway that is implicated in erythropoiesis”
From Red Blood Cells as Potential Repositories of MicroRNAs in the Circulatory System (2020) · cites this paper as Randrianarison-Huetz et al., 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cells
Hock, H., Hamblen, M. J., Rooke, H. M., Schindler, J. W., Saleque, S., Fujiwara, Y., & Orkin, S. H. (2004) · Nature · doi:10.1038/nature02994 · Cited by 541
Inflammatory reactions and severe neutropenia in mice lacking the transcriptional repressor Gfi1
Karsunky, H., Zeng, H., Schmidt, T., Zevnik, B., Kluge, R., Schmid, K. W., Dührsen, U., & Möröy, T. (2002) · Nature Genetics · doi:10.1038/ng831 · Cited by 315
Research works printed but not linked: 41
- Duan, 2003, Gfi-1 oncoproteins in hematopoiesis., Hematology, 8, 339, 10.1080/10245330310001612116 · DOI
- Grimes, 1996, The Gfi-1 proto-oncoprotein contains a novel transcriptional repressor domain, SNAG, and inhibits G1 arrest induced by interleukin-2 withdrawal., Mol Cell Biol, 16, 6263, 10.1128/MCB.16.11.6263 · DOI
- Tong, 1998, The Gfi-1B proto-oncoprotein represses p21WAF1 and inhibits myeloid cell differentiation., Mol Cell Biol, 18, 2462, 10.1128/MCB.18.5.2462 · DOI
- Zweidler-Mckay, 1996, Gfi-1 encodes a nuclear zinc finger protein that binds DNA and functions as a transcriptional repressor., Mol Cell Biol, 16, 4024, 10.1128/MCB.16.8.4024 · DOI
- Zeng, 2004, Transcription factor Gfi1 regulates self-renewal and engraftment of hematopoietic stem cells., EMBO J, 23, 4116, 10.1038/sj.emboj.7600419 · DOI
- Saleque, 2002, The zinc-finger proto-oncogene Gfi-1b is essential for development of the erythroid and megakaryocytic lineages., Genes Dev, 16, 301, 10.1101/gad.959102 · DOI
- Vassen, 2005, Direct transcriptional repression of the genes encoding the zinc-finger proteins Gfi1b and Gfi1 by Gfi1b., Nucleic Acids Res, 33, 987, 10.1093/nar/gki243 · DOI
- Gilks, 1993, Progression of interleukin-2 (IL-2)-dependent rat T cell lymphoma lines to IL-2-independent growth following activation of a gene (Gfi-1) encoding a novel zinc finger protein., Mol Cell Biol, 13, 1759, 10.1128/MCB.13.3.1759 · DOI
- Horman, 2009, Gfi1 integrates progenitor versus granulocytic transcriptional programming., Blood, 113, 5466, 10.1182/blood-2008-09-179747 · DOI
- Garcon, 2005, Gfi-1B plays a critical role in terminal differentiation of normal and transformed erythroid progenitor cells., Blood, 105, 1448, 10.1182/blood-2003-11-4068 · DOI
- Osawa, 2002, Erythroid expansion mediated by the Gfi-1B zinc finger protein: role in normal hematopoiesis., Blood, 100, 2769, 10.1182/blood-2002-01-0182 · DOI
- Vassen, 2007, Gfi1b:green fluorescent protein knock-in mice reveal a dynamic expression pattern of Gfi1b during hematopoiesis that is largely complementary to Gfi1., Blood, 109, 2356, 10.1182/blood-2006-06-030031 · DOI
- Laurent, 2009, Gfi-1B promoter remains associated with active chromatin marks throughout erythroid differentiation of human primary progenitor cells., Stem Cells, 27, 2153, 10.1002/stem.151 · DOI
- Saleque, 2007, Epigenetic regulation of hematopoietic differentiation by Gfi-1 and Gfi-1b is mediated by the cofactors CoREST and LSD1., Mol Cell, 27, 562, 10.1016/j.molcel.2007.06.039 · DOI
- Runyan, 2006, TGF-beta receptor-binding proteins: complex interactions., Cell Signal, 18, 2077, 10.1016/j.cellsig.2006.05.009 · DOI
- Lopez-Casillas, 1993, Betaglycan presents ligand to the TGF beta signaling receptor., Cell, 73, 1435, 10.1016/0092-8674(93)90368-Z · DOI
- Blobe, 2001, Functional roles for the cytoplasmic domain of the type III transforming growth factor beta receptor in regulating transforming growth factor beta signaling., J Biol Chem, 276, 24627, 10.1074/jbc.M100188200 · DOI
- Chen, 2003, Beta-arrestin 2 mediates endocytosis of type III TGF-beta receptor and down-regulation of its signaling., Science, 301, 1394, 10.1126/science.1083195 · DOI
- Finger, 2008, Endocytosis of the type III transforming growth factor-beta (TGF-beta) receptor through the clathrin-independent/lipid raft pathway regulates TGF-beta signaling and receptor down-regulation., J Biol Chem, 283, 34808, 10.1074/jbc.M804741200 · DOI
- Mythreye, 2009, The type III TGF-beta receptor regulates epithelial and cancer cell migration through beta-arrestin2-mediated activation of Cdc42., Proc Natl Acad Sci U S A, 106, 8221, 10.1073/pnas.0812879106 · DOI
- You, 2007, The type III TGF-beta receptor signals through both Smad3 and the p38 MAP kinase pathways to contribute to inhibition of cell proliferation., Carcinogenesis, 28, 2491, 10.1093/carcin/bgm195 · DOI
- You, 2009, The type III transforming growth factor-beta receptor negatively regulates nuclear factor kappa B signaling through its interaction with beta-arrestin2., Carcinogenesis, 30, 1281, 10.1093/carcin/bgp071 · DOI
- Compton, 2007, Coronary vessel development is dependent on the type III transforming growth factor beta receptor., Circ Res, 101, 784, 10.1161/CIRCRESAHA.107.152082 · DOI
- Stenvers, 2003, Heart and liver defects and reduced transforming growth factor beta2 sensitivity in transforming growth factor beta type III receptor-deficient embryos., Mol Cell Biol, 23, 4371, 10.1128/MCB.23.12.4371-4385.2003 · DOI
- He, 2006, Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway., Cell, 125, 929, 10.1016/j.cell.2006.03.045 · DOI
- Goardon, 2006, ETO2 coordinates cellular proliferation and differentiation during erythropoiesis., EMBO J, 25, 357, 10.1038/sj.emboj.7600934 · DOI
- Hempel, 2008, Expression of the type III TGF-beta receptor is negatively regulated by TGF-beta., Carcinogenesis, 29, 905, 10.1093/carcin/bgn049 · DOI
- Manz, 2002, Prospective isolation of human clonogenic common myeloid progenitors., Proc Natl Acad Sci U S A, 99, 11872, 10.1073/pnas.172384399 · DOI
- Alitalo, 1990, Induced differentiation of K562 leukemia cells: a model for studies of gene expression in early megakaryoblasts., Leuk Res, 14, 501, 10.1016/0145-2126(90)90002-Q · DOI · Paper page
- Chen, 1989, Effect of transforming growth factor-beta 1 on proliferation and induction of hemoglobin accumulation in K-562 cells., Blood, 74, 2368, 10.1182/blood.V74.7.2368.2368 · DOI
- Fiolka, 2006, Gfi1 and Gfi1b act equivalently in haematopoiesis, but have distinct, non-overlapping functions in inner ear development., EMBO Rep, 7, 326, 10.1038/sj.embor.7400618 · DOI
- Rodel, 2000, The zinc finger protein Gfi-1 can enhance STAT3 signaling by interacting with the STAT3 inhibitor PIAS3., EMBO J, 19, 5845, 10.1093/emboj/19.21.5845 · DOI
- Massague, 2005, Smad transcription factors., Genes Dev, 19, 2783, 10.1101/gad.1350705 · DOI
- Dong, 2006, Role of transforming growth factor-beta in hematologic malignancies., Blood, 107, 4589, 10.1182/blood-2005-10-4169 · DOI
- Ransom, 2004, The zebrafish moonshine gene encodes transcriptional intermediary factor 1gamma, an essential regulator of hematopoiesis., PLoS Biol, 2, E237, 10.1371/journal.pbio.0020237 · DOI
- Bhattacharyya, 2008, Smad-independent transforming growth factor-beta regulation of early growth response-1 and sustained expression in fibrosis: implications for scleroderma., Am J Pathol, 173, 1085, 10.2353/ajpath.2008.080382 · DOI
- Moustakas, 2005, Non-Smad TGF-beta signals., J Cell Sci, 118, 3573, 10.1242/jcs.02554 · DOI · Paper page
- Lewis, 2000, Betaglycan binds inhibin and can mediate functional antagonism of activin signalling., Nature, 404, 411, 10.1038/35006129 · DOI
- Kirkbride, 2008, Bone morphogenetic proteins signal through the transforming growth factor-beta type III receptor., J Biol Chem, 283, 7628, 10.1074/jbc.M704883200 · DOI
- Wiater, 2003, Inhibin is an antagonist of bone morphogenetic protein signaling., J Biol Chem, 278, 7934, 10.1074/jbc.M209710200 · DOI
- Lee, 2009, The transforming growth factor-beta type III receptor mediates distinct subcellular trafficking and downstream signaling of activin-like kinase (ALK)3 and ALK6 receptors., Mol Biol Cell, 20, 4362, 10.1091/mbc.e09-07-0539 · DOI
Cited by
Sorted by citations
Hinds, D. A., Barnholt, K. E., Mesa, R. A., Kiefer, A. K., Do, C. B., Eriksson, N., Mountain, J. L., Francke, U., Tung, J. Y., Nguyen, H. (., et al. (2016) · Blood · doi:10.1182/blood-2015-06-652941 · Cited by 267
Red Blood Cells as Potential Repositories of MicroRNAs in the Circulatory System
Sun, L., Yu, Y., Niu, B., & Wang, D. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00442 · Cited by 83
Polfus, L. M., Khajuria, R. K., Schick, U. M., Pankratz, N., Pazoki, R., Brody, J. A., Chen, M.-H., Auer, P. L., Floyd, J. S., Huang, J., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.06.016 · Cited by 54
Metadata
- Authors
- Randrianarison-Huetz, V., Laurent, B., Bardet, V., Blobe, G. C., Huetz, F., & Duménil, D.
- Affiliations
- Institut Cochin, Université Paris Descartes, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 8104, Paris, France;
- Departments of Medicine and Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC; and
- Unité d'Immunité Cellulaire Antivirale, Institut Pasteur, Paris, France
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2010-04-08
- Volume
- 115
- Issue
- 14
- Pages
- 2784-2795
- ISSN
- 0006-4971
- 1528-0020
- Cited by
- 82
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gfi-1B controls human erythroid and megakaryocytic differentiation by regulating TGF-β signaling at the bipotent erythro-megakaryocytic progenitor stage. https://app.cochat.ai/papers/10.1182/blood-2009-09-241752
- The paper
- Randrianarison-Huetz, V., Laurent, B., Bardet, V., Blobe, G. C., Huetz, F., & Duménil, D. (2010). Gfi-1B controls human erythroid and megakaryocytic differentiation by regulating TGF-β signaling at the bipotent erythro-megakaryocytic progenitor stage. Blood. https://doi.org/10.1182/blood-2009-09-241752